开发动脉瘤事件预测模型以指导常染色体显性多囊肾病影像监测
该回顾性队列研究纳入日本2个转诊中心的132例未治疗颅内动脉瘤的ADPKD成人患者,构建4分预测模型识别动脉瘤增大、形态改变、新发或破裂的复合结局,内部验证显示AUC 0.724,5年发生率低危0%、中危12%、高危46%。
要点
- 多发性动脉瘤(OR 5.56)是ADPKD患者动脉瘤事件的最强预测因子。
- 4分模型将患者分层为低危、中危和高危,5年复合结局发生率分别为0%、12%和46%。
- 模型需外部验证,谨慎推广。
核心结论
- 开发了内部验证的简易风险评分,用于预测ADPKD患者动脉瘤相关事件,但推广需谨慎并需外部验证。
研究设计与样本
- 回顾性队列研究,日本2个ADPKD转诊中心,2003-2024年1267例成人ADPKD患者中最终纳入132例未治疗颅内动脉瘤且有随访影像者。
主要发现
- 多发性动脉瘤(OR 5.56,p<0.001)、高血压(OR 3.60,p=0.063)和ADPKD家族史(OR 2.24,p=0.131)被选为评分变量,构成4分模型。
- 模型在推导队列和验证队列中区分度良好(表观AUC=0.724;乐观校正AUC=0.726)。
- 验证队列中按风险分组Kaplan-Meier曲线分层清晰,5年复合结局发生率低危0%、中危12%、高危46%。
关键数值与推荐
- 评分变量:多发性动脉瘤(OR 5.56,p<0.001)、高血压(OR 3.60,p=0.063)、ADPKD家族史(OR 2.24,p=0.131)。
- 4分风险评分模型,表观AUC=0.724,乐观校正AUC=0.726。
- 验证队列5年复合结局发生率:低危0%、中危12%、高危46%。
临床怎么用
- 可用于ADPKD合并未治疗颅内动脉瘤患者的风险分层,辅助制定影像随访策略。
局限性
- 可能存在选择偏倚,推广需谨慎,需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with autosomal dominant polycystic kidney disease (ADPKD) face a higher prevalence of intracranial aneurysms. However, the risk factors for aneurysmal events-particularly subarachnoid hemorrhage (SAH) or aneurysm growth, morphological changes, or de novo formation-remain poorly understood, leading to a lack of standardized policy of follow-up. This study aimed to identify predictors of such high-risk events and develop a risk prediction model to guide follow-up strategies. METHODS: This retrospective cohort study was conducted at 2 ADPKD referral centers in Japan. A total of 1267 adult patients with ADPKD who underwent brain imaging between 2003 and 2024 at 2 Japanese referral centers were eligible, and 132 patients with untreated intracranial aneurysms and follow-up imaging were finally included. The primary outcome was the composite of aneurysm growth, morphological change, de novo formation, or rupture. A multivariable logistic regression analysis was used to pick up variants for prediction model. Internal validation was performed in a validation cohort of 638 patients and also via bootstrapping (n = 2000). RESULTS: Multiple aneurysms (OR 5.56, p < 0.001), hypertension (OR 3.60, p = 0.063), and family history of ADPKD (OR 2.24, p = 0.131) were chosen as the scoring variables, resulting in the 4-point scoring model. This model demonstrated good prediction both in derivation and validation cohort discrimination (apparent AUC = 0.724; optimism-corrected AUC = 0.726). The Kaplan-Meier curves divided by the risk groups showed clear stratification, and the 5-year incidence of the composite outcome were 0% (low risk), 12% (moderate risk), and 46% (high risk) in the validation cohort. CONCLUSIONS: The authors developed an internally validated, easily applicable risk score for predicting aneurysm-related events in ADPKD patients. Generalization requires caution because of potential selection bias, and external validation is warranted.
引用
- Miyamoto S, Egashira S, Otomo Y, et al. Development of a prediction model for aneurysmal events to guide imaging surveillance in autosomal dominant polycystic kidney disease. J Neurosurg. 2026. PMID: 42826403. doi:10.3171/2026.4.JNS252347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。